Synonyms: 10009-20-8; H-Lys(Tfa)-OH; CHEBI:61064; N(6)-(trifluoroacetyl)-L-lysine; N(epsilon)-trifluoroacetyl-L-lysine; (S)-2-Amino-6-(2,2,2-trifluoroacetamido)hexanoic acid; J-502413; (2S)-2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid; (2S)-2-amino-6-(2,2,2-trifluoroacetylamino)hexanoic acid; MFCD00037223; C8H13F3N2O3; AK-41363; N-6-Trifluoroacetyl-L-lysine; Lysine, N6-(trifluoroacetyl)-, L-; H-L-Lys(Tfa)-OH; Epitope ID:150923; SCHEMBL875166; N-|A-Trifluoroacetyl-L-lysine; Jsp000057; CTK3J5148; DTXSID70142926; N~6~-(trifluoroacetyl)-L-lysine; PZZHRSVBHRVIMI-YFKPBYRVSA-N; N6-(Trifluoroacetyl)-L-lysine; Nepsilon -trifluoroacetyl-L-lysine; ACT07152; EBD47106; KS-00000FB3; ZINC2384794; ZX-AP012231; ANW-14156; PC1591; SBB058284; AKOS015920404; N6-Trifluoroacetyl-L-lysine; AKOS015924094; AAA0001523; AC-6228; AM81963; FCH3661839; RP17572; (S)-2-Amino-6-pivalamidohexanoic acid; N6-(2,2,2-trifluoroacetyl)-L-lysine; AJ-35123; AN-10221; N6-Trifluoroaccety-L-lysine; AS-12921; BC677967; BR-41363; CC-32256; SC-09733; L-Lysine, N6-(2,2,2-trifluoroacetyl)-; AB0004499; AX8010712; RT-002364; FT-0080237; epsilon-TFA-lysine; FT-0636611; ST24030746; ST51016163; N6-Trifluoroacetyl-L-lysine (for lisinopril); M-1703; (S)-6-trifluoroacetylamino-2-aminohexanoic acid; (2S)-2-amino-6-(trifluoroacetamido)hexanoic acid; 009H208; C-14566; Nepsilon-Trifluoroacetyl-L-lysine, >=96.0% (TLC); Nepsilon-Trifluoroacetyl-L-lysine; Potassium 3,6-dichloro-2-methoxybenzoate; Potassium 3,6-dichloro-o-anisate; C8-H13-F3-N2-O3; CID7009573; A7236; T2815; Nepsilon-Trifluoroacetyl-L-lysine, 98% - 25G 25g; 2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic Acid; (S)-6-(Trifluoroacetylamino)-2-aminohexanoic acid; N6-(Trifluoroacetyl)-L-lysine; N6-(Trifluoroacetyl)lysine;; L-Lysine, N6-(trifluoroacetyl)-; N(6)-trifluoroacetyl-L-lysine;